Endogenous Pituitary Adenylate Cyclase Activating Polypeptide Is Involved in Suppression of Edema in the Ischemic Brain

被引:30
|
作者
Nakamachi, Tomoya [1 ]
Ohtaki, Hirokazu [1 ]
Yofu, Sachiko [1 ]
Dohi, Kenji [1 ]
Watanabe, Jun [1 ]
Mori, Hiroyoshi [1 ]
Sato, Atsushi [1 ]
Hashimoto, Hitoshi [1 ]
Shintani, Norihito [1 ]
Baba, Akemichi [1 ]
Shioda, Seiji [1 ]
机构
[1] Showa Univ, Sch Med, Dept Anat, Shinagawa Ku, Tokyo 1428555, Japan
来源
BRAIN EDEMA XIV | 2010年 / 106卷
关键词
PACAP; brain edema; stroke; neural peptides; mouse; knockout; cerebral blood flow; PACAP; TISSUE; NEUROPROTECTION; AQUAPORIN-4; ASTROCYTES; EXPRESSION; RECEPTOR; DEATH; MICE;
D O I
10.1007/978-3-211-98811-4_6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Pituitary adenylate cyclase activating polypeptide is a pleiotropic neuropeptide. We previously showed that heterozygous PACAP gene knockout (PACAP(+/-)) mice had larger infarct volumes and worse neurological scores after middle cerebral artery occlusion (MCAO). However, the relationship between endogenous PACAP levels and edema in the ischemic brain has not yet been evaluated. In this study, the formation of edema in the ischemic brain as well as cerebral blood flow was compared between PACAP(+/-) and wild-type (PACAP(+/+)) mice. The amount of brain edema was calculated by subtracting the contralateral volume from the ipsilateral volume 24 h after permanent MCAO. PACAP(+/-) mice showed significantly greater brain edema than PACAP(+/+) mice. To investigate the effects of endogenous PACAP on blood flow during ischemia, cerebral blood flow in the ipsilateral and the contralateral cortices was compared between PACAP(+/-) and PACAP(+/+) mice for 25 min after ischemia. With a two-dimensional laser Doppler perfusion imaging system, the blood flow in the ipsilateral and contralateral cortices was shown to be similar in PACAP(+/-) and PACAP(+/+) mice during ischemia. These results suggest that endogenous PACAP suppresses the formation of edema in the ischemic brain.
引用
收藏
页码:43 / 46
页数:4
相关论文
共 50 条
  • [21] Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia
    R Hashimoto
    H Hashimoto
    N Shintani
    S Chiba
    S Hattori
    T Okada
    M Nakajima
    K Tanaka
    N Kawagishi
    K Nemoto
    T Mori
    T Ohnishi
    H Noguchi
    H Hori
    T Suzuki
    N Iwata
    N Ozaki
    T Nakabayashi
    O Saitoh
    A Kosuga
    M Tatsumi
    K Kamijima
    D R Weinberger
    H Kunugi
    A Baba
    Molecular Psychiatry, 2007, 12 : 1026 - 1032
  • [22] The pituitary adenylate cyclase activating polypeptide (PACAP):: A review.
    Mucio-Ramírez, S
    Miller-Pérez, C
    Curras-Collazo, M
    León-Olea, M
    SALUD MENTAL, 2004, 27 (02) : 55 - 69
  • [23] Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia
    Hashimoto, R.
    Hashimoto, H.
    Shintani, N.
    Chiba, S.
    Hattori, S.
    Okada, T.
    Nakajima, M.
    Tanaka, K.
    Kawagishi, N.
    Nemoto, K.
    Mori, T.
    Ohnishi, T.
    Noguchi, H.
    Hori, H.
    Suzuki, T.
    Iwata, N.
    Ozaki, N.
    Nakabayashi, T.
    Saitoh, O.
    Kosuga, A.
    Tatsumi, M.
    Kamijima, K.
    Weinberger, D. R.
    Kunugi, H.
    Baba, A.
    MOLECULAR PSYCHIATRY, 2007, 12 (11) : 1026 - 1032
  • [24] Effects of Pituitary Adenylate Cyclase Activating Polypeptide on Cell Death
    Horvath, Gabriella
    Reglodi, Dora
    Fabian, Eszter
    Opper, Balazs
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (09)
  • [25] Neurotrophic activity of pituitary adenylate cyclase-activating polypeptide
    Gonzalez, BJ
    Basille, M
    Vaudry, D
    Fournier, A
    Cazin, L
    Vaudry, H
    TRENDS IN COMPARATIVE ENDOCRINOLOGY AND NEUROBIOLOGY: FROM MOLECULAR TO INTEGRATIVE BIOLOGY, 1998, 839 : 551 - 552
  • [26] Pituitary Adenylate Cyclase-Activating Polypeptide in Learning and Memory
    Gilmartin, Marieke R.
    Ferrara, Nicole C.
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2021, 15
  • [27] Signaling cascades involved in neuroprotection by subpicomolar pituitary adenylate cyclase-activating polypeptide 38
    Min Li
    Csaba David
    Toshiteru Kikuta
    Aniko Somogyvari-Vigh
    Akira Arimura
    Journal of Molecular Neuroscience, 2005, 27 (1) : 91 - 105
  • [28] Signaling cascades involved in neuroprotection by subpicomolar pituitary adenylate cyclase-activating polypeptide 38
    David, C
    Kikuta, T
    Somogyvari-Vigh, A
    Arimura, A
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2005, 27 (01) : 91 - 105
  • [29] PASSAGE OF PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE(1-27) AND PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE(1-38) ACROSS THE BLOOD-BRAIN-BARRIER
    BANKS, WA
    KASTIN, AJ
    KOMAKI, G
    ARIMURA, A
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1993, 267 (02): : 690 - 696
  • [30] PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE IS A POTENT VASODILATOR AND EDEMA POTENTIATOR IN RABBIT SKIN INVIVO
    WARREN, JB
    LARKIN, SW
    COUGHLAN, M
    KAJEKAR, R
    WILLIAMS, TJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1992, 106 (02) : 331 - 334